智通财经APP讯,康宁杰瑞制药-B(09966)发布公告,左敏获委任为非执行董事兼董事会战略委员会成员,自2024年10月22日起生效。
王晋南因其他工作安排已辞任联席公司秘书,并不再担任《上市规则》第3.05条下授权代表的职务,自2024年10月22日起生效。
程湫滥已获委任为联席公司秘书,惟须遵守联交所授出的豁免,并获委任为授权代表,自2024年10月22日起生效。于上述变动后,陈泺而将继续担任另一位联席公司秘书。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.